Rare Disease Clinical Trials Market Size, Share, & Trends Report

Rare Disease Clinical Trials Market (2025 - 2030) Size, Share, & Trends Analysis Report By Phase (Phase I, Phase II, Phase III, Phase IV), By Therapeutic Area (Oncology, Cardiovascular), By Sponsor, By Region, And Segment Forecasts

Revenue, 2024 (US$M)
$12,961.6
Forecast, 2030 (US$M)
$19,019.9
CAGR, 2025 - 2030
6.8%
Report Coverage
Worldwide
Global rare disease clinical trials market, by region, 2018-2030 (US$M)
by regions
Global rare disease clinical trials market share,2024 & 2030 (%, US$M)
by region
Global rare disease clinical trials market: Opportunity assessment by country
by region
Global rare disease clinical trials market, by region, 2024 (US$M)
by region
Top 10 countries: Global rare disease clinical trials market size, 2024 (US$M)
by region
Global rare disease clinical trials market, by phase, 2018-2030 (US$M)
by region
Global rare disease clinical trials market, by therapeutic area, 2018-2030 (US$M)
by region
Global rare disease clinical trials market, by sponsor , 2018-2030 (US$M)
by region
Global rare disease clinical trials market, by region, 2018-2030 (US$M)
Global real world evidence solutions market size, by region, 2018-2030 (US$M)

Trusted market insights - try a free sample

See how our reports are structured and why industry leaders rely on Grand View Research. Get a free sample or ask us to tailor this report to your needs.

logo
GDPR & CCPA Compliant
logo
ISO 9001 Certified
logo
ISO 27001 Certified
logo
ESOMAR Member
Grand View Research is trusted by industry leaders worldwide
client logo
client logo
client logo
client logo
client logo
client logo